WEST BRIDGEWATER, Mass., Nov. 8 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. today announced that the Company will host a teleconference to discuss its third quarter financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone or through a live web-cast. The teleconference and web-cast information is provided below:
Date: Monday, November 12, 2007
Time: 4:30 p.m. Eastern Standard Time (EST)
To attend this teleconference via web-cast, please go to the Company’s website: www.pressurebiosciences.com
For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call ends through December 10, 2007, and will be accessible through the Company’s website.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBI) is a publicly traded, company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.
CONTACT: Richard T. Schumacher, President & CEO, or Edward H. Myles,
Senior Vice President of Finance & CFO, +1-508-580-1818, both of Pressure
BioSciences, Inc.
Web site: http://www.pressurebiosciences.com/
